QIAGEN announces exclusive global commercial partnership with Bode Technology. Per the agreement, Bode will manage all commercial transactions for QIAGEN's GEDmatch PRO globally.

Diffuse midline glioma (DMG) is a highly aggressive and fatal pediatric high-grade glioma that primarily affects critical regions of the central nervous system, such as the pons, thalamus, and spinal ...

Children's Hospital of Michigan is treating the first person in Michigan with a newly approved gene-editing therapy for beta thalassemia.

Miplyffa treats Niemann-Pick disease type C, which progressively impacts the abilities to speak, swallow, and walk or move ...

Whether you're looking for the best kids' movies on Netflix, new releases on Disney+, the latest TV shows for teens on Amazon Prime, or what you can watch for free on Tubi, we've got you covered! And ...